These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9869869)

  • 1. Tolerance induction for islet transplantation.
    Exner BG; Fowler K; Ildstad ST
    Ann Transplant; 1997; 2(3):77-80. PubMed ID: 9869869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of bone marrow transplantation on type I diabetes.
    Domenick MA; Ildstad ST
    World J Surg; 2001 Apr; 25(4):474-80. PubMed ID: 11344401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat.
    Itakura S; Asari S; Rawson J; Ito T; Todorov I; Liu CP; Sasaki N; Kandeel F; Mullen Y
    Am J Transplant; 2007 Feb; 7(2):336-46. PubMed ID: 17283484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimerism and tolerance: from freemartin cattle and neonatal mice to humans.
    Jankowski RA; Ildstad ST
    Hum Immunol; 1997 Feb; 52(2):155-61. PubMed ID: 9077564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic NOD mice.
    Guo Z; Wu T; Sozen H; Pan Y; Heuss N; Kalscheuer H; Sutherland DE; Blazar BR; Hering BJ
    Transplantation; 2003 Apr; 75(7):909-15. PubMed ID: 12698073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A more persistent tolerance to islet allografts through bone marrow transplantation in minimal nonmyeloablative conditioning therapy.
    Lee BW; Lee JI; Oh SH; Ahn YR; Chae HY; Lee MS; Lee MK; Kim KW
    Transplant Proc; 2005 Jun; 37(5):2266-9. PubMed ID: 15964395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of chimerism permits low-dose islet grafts in the liver or pancreas to reverse refractory autoimmune diabetes.
    Zhang C; Wang M; Racine JJ; Liu H; Lin CL; Nair I; Lau J; Cao YA; Todorov I; Atkinson M; Zeng D
    Diabetes; 2010 Sep; 59(9):2228-36. PubMed ID: 20530743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches for control of anti-self-reactivity in type 1 diabetes and transplantation of pancreatic islets.
    Slavin S; Weiss L; Prighozina T; Gurevitch O; Zhu J; Rabstein I; Gross D
    Transplant Proc; 1997 Jun; 29(4):1929-31. PubMed ID: 9193459
    [No Abstract]   [Full Text] [Related]  

  • 10. Increasing donor chimerism and inducing tolerance to islet allografts by post-transplant donor lymphocyte infusion.
    Liu B; Hao J; Pan Y; Luo B; Westgard B; Heremans Y; Sutherland DE; Hering BJ; Guo Z
    Am J Transplant; 2006 May; 6(5 Pt 1):933-46. PubMed ID: 16611329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC-mismatched chimerism is required for induction of transplantation tolerance in autoimmune nonobese diabetic recipients.
    Wang M; Racine J; Zhang M; Wu T; Deng R; Johnston H; Shen C; Siswanto K; Zeng D
    J Immunol; 2014 Aug; 193(4):2005-15. PubMed ID: 25000982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet transplantation in Type-I diabetes: current state and prospects.
    Mandel TE
    Ann Acad Med Singap; 1991 Jul; 20(4):513-8. PubMed ID: 1799266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined islet and hematopoietic stem cell allotransplantation: a clinical pilot trial to induce chimerism and graft tolerance.
    Mineo D; Ricordi C; Xu X; Pileggi A; Garcia-Morales R; Khan A; Baidal DA; Han D; Monroy K; Miller J; Pugliese A; Froud T; Inverardi L; Kenyon NS; Alejandro R
    Am J Transplant; 2008 Jun; 8(6):1262-74. PubMed ID: 18444924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tregs and Mixed Chimerism as Approaches for Tolerance Induction in Islet Transplantation.
    Pathak S; Meyer EH
    Front Immunol; 2020; 11():612737. PubMed ID: 33658995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed allogeneic chimerism to induce tolerance to solid organ and cellular grafts.
    Exner BG; Acholonu IN; Bergheim M; Mueller YM; Ildstad ST
    Acta Haematol; 1999; 101(2):78-81. PubMed ID: 10202237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Xenotransplantation of islets of Langerhans: a possible therapy for diabetes mellitus?].
    Igaz P
    Wien Med Wochenschr; 2001; 151(13-14):291-4. PubMed ID: 11582992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injection of bone marrow cells into the thymus to achieve tolerance in an islet xenotransplant (human-to-rat) model.
    Dellagiacoma G; Rossi M; Castagna MT; Radin S; Vecchioni R
    Transplant Proc; 1994 Jun; 26(3):1114-5. PubMed ID: 8029850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.